Eye Health Summit: 'Create one vision health message'

Article

More than 110 vision community representatives gathered at the Eye Health Summit in July to build consensus in the vision community on a public health/eye health message and to outline an implementation plan for delivering the message.

Key Points

Chicago-More than 110 vision community representatives gathered at the Eye Health Summit in July to build consensus in the vision community on a public health/eye health message and to outline an implementation plan for delivering the message.

Vision problems are the second most prevalent health problem in the United States, affecting more than 120 million Americans, according to a report from the summit. The summit focused on building a unified public health message that could lead to earlier diagnosis of disease and improved quality of life.

"By bringing together professional associations, trade associations, major manufacturers, non-profit groups, retailers, vision-care plans, and government agencies, we hope to take meaningful steps to improving Americans' eye health," said Ed Greene, chief executive officer of The Vision Council, which hosted the summit.

Recent Videos
Rachelle Lin, OD, MS, FAAO, details her presentation on inherited retinal diseases at CRU 2025.
Setting the stage in LA: Neda Shamie, MD, on the 19th annual Controversies in Modern Eye Care meeting
Jennifer Li, MD, details a talk she gave alongside Melissa Barnett, OD, FAAO, FSLS, FBCLA, at CRU 2025 in Napa, California.
Deb Ristvedt, DO, details a handful of presentations on glaucoma she gave during CRU 2025 in Napa, California.
Cecelia Koetting, OD, FAAO, DipABO, weighs in on patient assessments, staining pattern insights, and diagnostic tips for patients who may have dry eye disease.
Melissa Barnett, OD, FAAO, FSLS, FBCLA, discusses keratoconus management, diagnosis, and other key insights at CRU 2025.
Cecelia Koetting, OD, FAAO, DipABO, details a talk she gave among optometrists and ophthalmologists at CRU 2025.
Alongside Rachelle Lin, OD, MS, FAAO; Nguyễn, MD, MSc, detailed what treatments are currently available for retinal vascular diseases, including neovascular age-related macular degeneration and diabetic retinopathy.
Dr Paul Karpecki discusses atropine formulation from Sydnexis following NDA acceptance by FDA
Ali Tafreshi sits down with Optometry Times to discuss Topcon's "Healthcare from the Eye" initiative.
© 2025 MJH Life Sciences

All rights reserved.